Company Analysis Unichem Laboratories Limited
1. Summary
Advantages
- The stock's return over the last year (51.44%) is higher than the sector average (-41.78%).
Disadvantages
- Price (676.25 βΉ) is higher than fair price (607.51 βΉ)
- Dividends (0%) are below the sector average (0.6496%).
- Current debt level 6.91% has increased over 5 years from 0%.
- The company's current efficiency (ROE=-2.94%) is lower than the sector average (ROE=3.69%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Unichem Laboratories Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -5.4% | -1.9% | 0.5% |
| 90 days | -8.1% | -1.2% | -2.1% |
| 1 year | 51.4% | -41.8% | 7.9% |
UNICHEMLAB vs Sector: Unichem Laboratories Limited has outperformed the "Healthcare" sector by 93.22% over the past year.
UNICHEMLAB vs Market: Unichem Laboratories Limited has outperformed the market by 43.53% over the past year.
Stable price: UNICHEMLAB is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: UNICHEMLAB with weekly volatility of 0.9893% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (676.25 βΉ) is higher than the fair price (607.51 βΉ).
Price is higher than fair: The current price (676.25 βΉ) is 10.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (57.27) is higher than that of the sector as a whole (56.11).
P/E vs Market: The company's P/E (57.27) is higher than that of the market as a whole (43.66).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.48) is lower than that of the sector as a whole (8.08).
P/BV vs Market: The company's P/BV (1.48) is lower than that of the market as a whole (6.15).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.1) is lower than that of the sector as a whole (17.79).
P/S vs Market: The company's P/S indicator (2.1) is lower than that of the market as a whole (8.67).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-45.16) is lower than that of the sector as a whole (4.22).
EV/Ebitda vs Market: The company's EV/Ebitda (-45.16) is lower than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 3.42% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (3.42%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-17.15%).
5.4. ROE
ROE vs Sector: The company's ROE (-2.94%) is lower than that of the sector as a whole (3.69%).
ROE vs Market: The company's ROE (-2.94%) is lower than that of the market as a whole (-0.3088%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.22%) is lower than that of the sector as a whole (3.44%).
ROA vs Market: The company's ROA (-2.22%) is lower than that of the market as a whole (7.53%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-7.39%) is lower than that of the sector as a whole (11.26%).
ROIC vs Market: The company's ROIC (-7.39%) is lower than that of the market as a whole (16.2%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.6496%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (-0.1056%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
